Latest debt-to-equity ratio
Seres Therapeutics Debt-to-equity ratio
Direct answer
Seres Therapeutics's debt-to-equity ratio is 164.02%.
The verified market snapshot reports 164.02%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 164.02%
Explore related company data
View Seres Therapeutics's market capitalizationView Seres Therapeutics's price-to-book ratioView Seres Therapeutics's return on equityView Seres Therapeutics's dividend yieldView Seres Therapeutics's 52-week price rangeView Seres Therapeutics's profit marginView all Seres Therapeutics key metricsReturn to Seres Therapeutics profile